68Ga-DOTA-IBA Uptake in Breast cancer

Clin Nucl Med. 2024 Mar 25. doi: 10.1097/RLU.0000000000005200. Online ahead of print.ABSTRACTA 77-year-old woman with recently diagnosed breast cancer underwent 68Ga-labeled DOTA-ibandronic acid (68Ga-DOTA-IBA) PET/CT scan for the evaluation of bone metastases. The examination revealed increased tracer uptake, indicating that the cervical vertebrae presented osteoblastic metastasis. Interestingly, the breast cancer also showed enhanced activity of 68Ga-DOTA-IBA.PMID:38537211 | DOI:10.1097/RLU.0000000000005200
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Source Type: research